background chikungunya virus child reemerg arboviru assoc fabric ill often accompany rash arthralgia may persist sever year outbreak high morbid create public health challenge country affect recent occur europ america suggest continue spread despite sustain threat approve vaccine antivirus therapy therefore critic develop well tower highly protect methodologyprincip find studi describe construct character modify vaccine kara ma express e protein machi protect mouse model particular basic mouse complete viremia upon two dose admit deficit inαβ footed swell mortal antivirus antibody elicit low detect level neutral product howe passive transfer immune serum naïv protect main effector protect afford furthermore delete cd cell vaccine result italic indispens role conclusionssignific result present herein demons potent effect express ee genre response assume effect provide provide framework develop novel strategy combat 